Subject
Health Policy,Medicine (miscellaneous)
Reference124 articles.
1. Abouchedid, R., Gilks, T., Dargan, P. I., Archer, J. R. H., & Wood, D. M. (2018). Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances-benzodiazepines diclazepam, flubromazepam, and pyrazolam-in the UK. Journal of Medical Toxicology, 14(2)(2), 134–143. https://doi.org/http://dx.doi.org/10.1007/s13181-018-0659-3
2. Advisory Council on the Misuse of Drugs. (2016). Part of: Drug misuse and dependency Advice on U-47,700, etizolam and other designer benzodiazepines. .
3. Application of a molecular networking approach for clinical and forensic toxicology exemplified in three cases involving 3-MeO-PCP, doxylamine, and chlormequat;Allard;Drug Testing and Analysis,2019
4. The slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum;Andersson;Nordic Studies on Alcohol and Drugs,2017
5. Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube;Andersson;Harm Reduction Journal,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献